Active Ingredient: DABRAFENIB MESYLATE
Proprietary Name: TAFINLAR
Dosage Form; Route of Administration: TABLET, FOR SUSPENSION; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217514
Product Number: 001
Approval Date: Mar 16, 2023
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information